Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Lenvatinib plus sintilimab versus lenvatinib monotherapy as first-line treatment for advanced HBV-related hepatocellular carcinoma: A retrospective, real-world study
PaperCitations, authors & open-access status
Lenvatinib plus sintilimab versus lenvatinib monotherapy as first-line treatment for advanced HBV-related hepatocellular carcinoma: A retrospective, real-world study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 25 citations, 2022 year and gold oa status.
25
Citations
2022
Year
gold
OA Status